Release Date: 11/12/17 09:48 Summary: Preliminary Final Report 2017 Price Sensitive: No Download Document 1.36MB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%